Skip to content

QuidelOrtho Corporation QDEL Free cash flow margin

Discontinued — last reported Q1 '23

Free cash flow margin at other companies

Abbott logo
AbbottABT
16.3%+0.6pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
13.8%-0.2pp
Danaher logo
DanaherDHR
21.4%+0.8pp
Revvity logo
RevvityRVTY
17%-1.9pp
Quest Diagnostics logo
Quest DiagnosticsDGX
11.8%+1.4pp
Opko Health logo
Opko HealthOPK
-30%+0.1pp

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Calculated from QuidelOrtho Corporation’s reported figures.

Based on trailing twelve months.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 9, 2024, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's free cash flow margin?
QuidelOrtho Corporation (QDEL) reported free cash flow margin of 13.8% in Q1 2023.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.